These findings collectively demonstrate that fer-1 treatment abrogates FASN silencing-mediated alterations in cholesterol metabolism and ferroptosis-related indicators in CRC cells, confirming FASN as a critical regulatory factor for cholesterol metabolism and ferroptosis in CRC cells. Here, FASN is linked to colorectal carcinoma.